Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew T Warkentin

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Ebiomedicine|September 10, 2019
Determinants of impaired lung function and lung cancer prediction among never-smokers in the UK Biobank cohortMatthew T Warkentin, Stephen Lam, Rayjean J Hung
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 18, 2024
Risk of Developing a Subsequent Primary Cancer among Adult Cancer SurvivorsMatthew T Warkentin, Winson Y Cheung, Darren R Brenner, et al.
Cancer Medicine|July 10, 2024
Examining external control arms in oncology: A scoping review of applications to dateEliya Farah, Matthew Kenney, Matthew T Warkentin, et al.
Cancer Control : Journal of the Moffitt Cancer Center|March 22, 2024
Next Generation Weight Loss Drugs for the Prevention of Cancer?Chantelle Carbonell, Mariet Mathew Stephen, Yibing Ruan, et al.
Annals of Internal Medicine|April 17, 2020
Estimating the Maximum Capacity of COVID-19 Cases Manageable per Day Given a Health Care System's Constrained ResourcesVasily Giannakeas, Deepit Bhatia, Matthew T Warkentin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 29, 2018
Heritable Germline Variation and Lung Cancer Susceptibility: One Size Does not Fit AllMichael Herman, Matthew T Warkentin, Daniel Shepshelovich, et al.
Cancer Epidemiology|April 23, 2023
Probability of lung cancer in a population excluded from screening due to low PLCO<sub>M2012</sub> riskPaul MacEachern, Matthew T Warkentin, Darren R Brenner, et al.
JCO Global Oncology|July 9, 2026
Progress in Colorectal Cancer Mortality Across 48 Countries: The Impact of Screening and Early DetectionDarren R Brenner, Matthew T Warkentin, Derek Tilley, et al.
Cancer Epidemiology|February 21, 2025
Age-specific lung cancer incidence trends in Canada from 1992 to 2022Matthew T Warkentin, Johnathan A Murray, Yibing Ruan, et al.
JCO Oncology Advances|July 16, 2025
Increasing Cervical Cancer Rates Among Women Age 35-54 Years in Canada: Age-Specific Cervical Cancer Incidence Trends in Canada, 1992-2022Ioana A Nicolau, Matthew T Warkentin, Kirk Graff, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Ebiomedicine|September 10, 2019
Determinants of impaired lung function and lung cancer prediction among never-smokers in the UK Biobank cohortMatthew T Warkentin, Stephen Lam, Rayjean J Hung
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 18, 2024
Risk of Developing a Subsequent Primary Cancer among Adult Cancer SurvivorsMatthew T Warkentin, Winson Y Cheung, Darren R Brenner, et al.
Cancer Medicine|July 10, 2024
Examining external control arms in oncology: A scoping review of applications to dateEliya Farah, Matthew Kenney, Matthew T Warkentin, et al.
Cancer Control : Journal of the Moffitt Cancer Center|March 22, 2024
Next Generation Weight Loss Drugs for the Prevention of Cancer?Chantelle Carbonell, Mariet Mathew Stephen, Yibing Ruan, et al.
Annals of Internal Medicine|April 17, 2020
Estimating the Maximum Capacity of COVID-19 Cases Manageable per Day Given a Health Care System's Constrained ResourcesVasily Giannakeas, Deepit Bhatia, Matthew T Warkentin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 29, 2018
Heritable Germline Variation and Lung Cancer Susceptibility: One Size Does not Fit AllMichael Herman, Matthew T Warkentin, Daniel Shepshelovich, et al.
Cancer Epidemiology|April 23, 2023
Probability of lung cancer in a population excluded from screening due to low PLCO<sub>M2012</sub> riskPaul MacEachern, Matthew T Warkentin, Darren R Brenner, et al.
JCO Global Oncology|July 9, 2026
Progress in Colorectal Cancer Mortality Across 48 Countries: The Impact of Screening and Early DetectionDarren R Brenner, Matthew T Warkentin, Derek Tilley, et al.
Cancer Epidemiology|February 21, 2025
Age-specific lung cancer incidence trends in Canada from 1992 to 2022Matthew T Warkentin, Johnathan A Murray, Yibing Ruan, et al.
JCO Oncology Advances|July 16, 2025
Increasing Cervical Cancer Rates Among Women Age 35-54 Years in Canada: Age-Specific Cervical Cancer Incidence Trends in Canada, 1992-2022Ioana A Nicolau, Matthew T Warkentin, Kirk Graff, et al.
Pageof 5